S. Luchetti

Medicine & Life Sciences

1. 1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine 30%
2. 11-beta-Hydroxysteroid Dehydrogenases 9%
3. 20-alpha-Dihydroprogesterone 38%
4. alcohol sulfotransferase 11%
5. Aminobutyrates 7%
6. Autopsy 39%
7. Basal Ganglia 10%
8. Biosynthetic Pathways 45%
9. Bipolar Disorder 12%
10. Brain 57%
11. Brain Diseases 40%
12. Brain-Derived Neurotrophic Factor 19%
13. Chronic Progressive Multiple Sclerosis 10%
14. Cohort Studies 25%
15. Dehydroepiandrosterone 22%
16. Dehydroepiandrosterone Sulfate 33%
17. Demyelinating Diseases 8%
18. Gene Expression 9%
19. Gyrus Cinguli 25%
20. Histamine 10%
21. Histamine Receptors 50%
22. In Vitro Techniques 9%
23. Inflammation 22%
24. Ketosteroids 10%
25. Macrophages 11%
26. Major Depressive Disorder 26%
27. Messenger RNA 21%
28. Microglia 28%
29. Monocytes 12%
30. Mood Disorders 36%
31. Multiple Sclerosis 100%
32. Neuroprotective Agents 38%
33. Neurosteroids 50%
34. Parkinson Disease 63%
35. Pathology 50%
36. Prefrontal Cortex 42%
37. Pregnanolone 54%
38. Primary Cell Culture 9%
39. Protein-Tyrosine Kinases 17%
40. Purinergic P2X7 Receptors 53%
41. Relapsing-Remitting Multiple Sclerosis 9%
42. Serotonin 9%
43. Single Nucleotide Polymorphism 31%
44. steroidogenic acute regulatory protein 9%
45. Steroids 38%
46. Substantia Nigra 26%
47. Synucleins 8%
48. Therapeutics 7%
49. Tissue Donors 9%
50. Up-Regulation 10%